Detail
LncRNA Name | PVT1 |
Synonyms | PVT1, LINC00079, MYC, NCRNA00079, onco-lncRNA-100, MIR1204HG |
Region | GRCh38_8:127794533-128101253 Sequence |
Ensembl | ENSG00000249859 |
RefSeq | NR_003367 |
Circulating | ✘ |
Drug-resisitant | ✘ |
Prognostic | ✘ |
MiRNA | ✔ |
Variant | ✘ |
TF | ✘ |
Methylation | ✔ |
Cancer Name | prostate cancer |
ICD-0-3 | C61.9 |
Methods | qPCR, MSP-PCR, RNAi etc. |
Sample | prostate cancer tissues, cell lines (LNCaP, PC-3 and DU145) |
Expression Pattern | up-regulated |
Function Description | Our results showed that miR-146a was downregulated and negatively correlated with PVT1 level in prostate cancer. PVT1 mediated miR-146a expression by inducing the methylation of CpG Island in its promoter. miR-146a overexpression eliminated the effects of PVT1 knockdown on prostate cancer cells. PVT1 regulated prostate cancer cell viability and apoptosis depending on miR-146a. |
Pubmed ID | 27794184 |
Year | 2016 |
Title | LncRNA PVT1 regulates prostate cancer cell growth by inducing the methylation of miR-146a. |
External Links |
Links for PVT1 | GenBank HGNC lncrnadb Noncode |
Links for prostate cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.